Hashimoto Y - Search Results

1

Application of protein knockdown strategy targeting β-sheet structure to multiple disease-associated polyglutamine proteins.

Yamashita H, Tomoshige S, Nomura S, Ohgane K, Hashimoto Y, Ishikawa M. Yamashita H, et al. Among authors: hashimoto y. Bioorg Med Chem. 2020 Jan 1;28(1):115175. doi: 10.1016/j.bmc.2019.115175. Epub 2019 Oct 31. Bioorg Med Chem. 2020. PMID: 31767406

2

Structural development of biological response modifiers based on thalidomide.

Hashimoto Y. Hashimoto Y. Bioorg Med Chem. 2002 Mar;10(3):461-79. doi: 10.1016/s0968-0896(01)00308-x. Bioorg Med Chem. 2002. PMID: 11814832 Review.

3

Novel non-steroidal/non-anilide type androgen antagonists with an isoxazolone moiety.

Ishioka T, Kubo A, Koiso Y, Nagasawa K, Itai A, Hashimoto Y. Ishioka T, et al. Among authors: hashimoto y. Bioorg Med Chem. 2002 May;10(5):1555-66. doi: 10.1016/s0968-0896(01)00421-7. Bioorg Med Chem. 2002. PMID: 11886817

4

Thalidomide and its analogues as cyclooxygenase inhibitors.

Noguchi T, Shimazawa R, Nagasawa K, Hashimoto Y. Noguchi T, et al. Among authors: hashimoto y. Bioorg Med Chem Lett. 2002 Apr 8;12(7):1043-6. doi: 10.1016/s0960-894x(02)00084-7. Bioorg Med Chem Lett. 2002. PMID: 11909713

5

Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actions.

Takahashi B, Ohta K, Kawachi E, Fukasawa H, Hashimoto Y, Kagechika H. Takahashi B, et al. Among authors: hashimoto y. J Med Chem. 2002 Aug 1;45(16):3327-30. doi: 10.1021/jm0255320. J Med Chem. 2002. PMID: 12139443

6

Structural development of biological response modifiers based on retinoids and thalidomide.

Hashimoto Y. Hashimoto Y. Mini Rev Med Chem. 2002 Dec;2(6):543-51. doi: 10.2174/1389557023405576. Mini Rev Med Chem. 2002. PMID: 12370039 Review.

7

Synthesis and mechanism of action of novel pyrimidinyl pyrazole derivatives possessing antiproliferative activity.

Ohki H, Hirotani K, Naito H, Ohsuki S, Minami M, Ejima A, Koiso Y, Hashimoto Y. Ohki H, et al. Among authors: hashimoto y. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3191-3. doi: 10.1016/s0960-894x(02)00568-1. Bioorg Med Chem Lett. 2002. PMID: 12372531

8

Fluorescent bioprobes for visualization of puromycin-sensitive aminopeptidase in living cells.

Kakuta H, Koiso Y, Nagasawa K, Hashimoto Y. Kakuta H, et al. Among authors: hashimoto y. Bioorg Med Chem Lett. 2003 Jan 6;13(1):83-6. doi: 10.1016/s0960-894x(02)00845-4. Bioorg Med Chem Lett. 2003. PMID: 12467622

9

Anti-androgens with full antagonistic activity toward human prostate tumor LNCaP cells with mutated androgen receptor.

Ishioka T, Tanatani A, Nagasawa K, Hashimoto Y. Ishioka T, et al. Among authors: hashimoto y. Bioorg Med Chem Lett. 2003 Aug 18;13(16):2655-8. doi: 10.1016/s0960-894x(03)00575-4. Bioorg Med Chem Lett. 2003. PMID: 12873487

10

Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.

Kato Y, Nakano Y, Sano H, Tanatani A, Kobayashi H, Shimazawa R, Koshino H, Hashimoto Y, Nagasawa K. Kato Y, et al. Among authors: hashimoto y. Bioorg Med Chem Lett. 2004 May 17;14(10):2579-83. doi: 10.1016/j.bmcl.2004.02.076. Bioorg Med Chem Lett. 2004. PMID: 15109656

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results